id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2000-P-0126-0006,FDA,FDA-2000-P-0126,Milk & Cream Products & Yogurt Products; Petition to Revoke Standards for Lowfat Yogurt & Nonfat Yogurt & to Amend Standards for Yogurt and Cultured Milk; Reopening of the Comment Period,Proposed Rule,NEC-Notice of Extension,2003-10-31T05:00:00Z,2003,10,2003-10-28T05:00:00Z,2004-01-28T04:59:59Z,2009-03-31T18:12:20Z,,0,0,09000064804cf56d
FDA-1978-N-0021-0014,FDA,FDA-1978-N-0021,Notice of Proposed Rulemaking re Laxative Drug Products for Over-the-Counter Human Use; Reopening of the Administrative Record,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2003-10-23T04:00:00Z,2003,10,2003-10-22T04:00:00Z,2004-01-21T04:59:59Z,2016-08-09T20:43:30Z,,0,0,090000648055d669
FDA-2003-N-0097-0001,FDA,FDA-2003-N-0097,"Revisions to Labeling and Storage Requirements for Blood and Blood Components, Including Source Plasma",Proposed Rule,Notice of Proposed Rulemaking (NPRM),2003-07-31T04:00:00Z,2003,7,2003-07-30T04:00:00Z,2003-10-29T04:59:59Z,2025-03-06T13:46:14Z,03-19289,0,0,09000064804839c0
FDA-1978-N-0022-0020,FDA,FDA-1978-N-0022,External Analgesic Drug Products for Over-the-Counter Human Use; Reopening of the Administrative Record and Amendment of Tentative Final Monograph,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2003-07-17T04:00:00Z,2003,7,2003-07-15T04:00:00Z,2003-10-16T03:59:59Z,2020-02-05T16:13:10Z,03-17934,0,0,090000648055ec5f
FDA-2000-P-0126-0001,FDA,FDA-2000-P-0126,Milk & Cream Products & Yogurt Products; Petition to RevokeStandards for Lowfat Yogurt & Nonfat Yogurt & to Amend Standards for Yogurt & Cultured Milk,Proposed Rule,NAP-Advanced Notice of Proposed Rulemaking,2003-07-08T04:00:00Z,2003,7,2003-07-03T04:00:00Z,2003-10-02T03:59:59Z,2009-03-31T18:11:43Z,,0,0,09000064804cf4dc
FDA-1995-N-0063-0004,FDA,FDA-1995-N-0063,"Current Good Manufacturing Practice, Quality Control Procedures, Quality Factors, Notification Requirements, and Records and Reports for the Production of Infant Formula; Extension of Reopening of the Comment Period",Proposed Rule,Extension of Comment Period,2003-07-02T04:00:00Z,2003,7,2003-06-27T04:00:00Z,2003-08-27T03:59:59Z,2014-05-03T01:05:13Z,68 FR 38247,0,0,090000648056cb33
FDA-2000-N-0108-0007,FDA,FDA-2000-N-0108,Safety Reporting Requirements for Human Drug and Biological Products; Extension of Comment Period,Proposed Rule,NEC-Notice of Extension,2003-07-01T04:00:00Z,2003,7,2003-06-17T04:00:00Z,2003-10-15T03:59:59Z,2016-12-21T02:02:24Z,,0,0,09000064804c2749
FDA-1977-N-0025-0005,FDA,FDA-1977-N-0025,"Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-the-Counter Human Use; Proposed Amendment of the Tentative Final Monograph, and Related Labeling; Reopening of Comment Period",Proposed Rule,Notice of Proposed Rulemaking (NPRM),2003-06-13T04:00:00Z,2003,6,2003-06-04T04:00:00Z,2003-09-03T03:59:59Z,2019-02-11T13:51:24Z,03-13914,0,0,09000064805da2d9
FDA-1981-N-0015-0005,FDA,FDA-1981-N-0015,Advance Notice of Proposed Rule from FDA/CDER re Oral Health Care Drug Products for Over-the-Counter Human Use Antigingivitis/Antiplaque Drug Products; Establishment of a Monograph,Proposed Rule,Advance Notice of Proposed Rulemaking (ANPRM),2003-06-03T04:00:00Z,2003,6,2003-05-29T04:00:00Z,2003-08-28T03:59:59Z,2015-05-27T15:40:23Z,,0,0,09000064805aed28
FDA-1981-N-0015-0006,FDA,FDA-1981-N-0015,Advance Notice of Proposed Rule from FDA/CDER re Oral Health Care Drug Products for Over-the-Counter Human Use Antigingivitis/Antiplaque Drug Products; Establishment of a Monograph,Proposed Rule,Advance Notice of Proposed Rulemaking (ANPRM),2003-06-03T04:00:00Z,2003,6,2003-05-29T04:00:00Z,2003-08-28T03:59:59Z,2015-05-27T15:42:27Z,,0,0,09000064805aed29
FDA-1981-N-0015-0007,FDA,FDA-1981-N-0015,Advance Notice of Proposed Rulemaking FDA/CDER re Oral Health Care Drug Products for Over-the-Counter Human Use; Antigingivitis/Antiplaque Drug Products; Establishment of a Monograph,Proposed Rule,Advance Notice of Proposed Rulemaking (ANPRM),2003-06-03T04:00:00Z,2003,6,2003-05-29T04:00:00Z,2003-08-28T03:59:59Z,2015-06-09T18:29:40Z,,0,0,09000064805aed2a
FDA-2002-N-0033-0003,FDA,FDA-2002-N-0033,Notice of Proposed Rule Making from FDA/CFSAN  re   Bioterrorism Preparedness; Administrative Detention,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2003-05-28T04:00:00Z,2003,5,2003-07-08T04:00:00Z,,2015-04-06T14:53:38Z,,0,0,090000648048aaaa
FDA-1995-N-0063-0001,FDA,FDA-1995-N-0063,"Current Good Manufacturing Practice, Quality Control Procedures, Quality Factors, Notification Requirements, and Records and Reports for the Production of Infant Formula; Reopening of the Comment Period",Proposed Rule,Reopening of Comment Period,2003-05-01T04:00:00Z,2003,5,2003-05-01T04:00:00Z,2003-06-28T03:59:59Z,2014-07-17T01:03:16Z,,0,0,090000648056caaf
FDA-1996-P-0246-0023,FDA,FDA-1996-P-0246,Withdrawal of Certain Proposed Rules and Other Proposed Actions; Notice of Intent,Proposed Rule,Withdrawal,2003-04-22T04:00:00Z,2003,4,2014-02-20T05:00:00Z,2003-04-23T03:59:59Z,2014-02-20T14:36:55Z,,0,0,0900006480503989
FDA-2002-N-0263-0001,FDA,FDA-2002-N-0263,General and Plastic Surgery Devices; Classification of Silicone Sheeting,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2003-03-26T00:00:00Z,2003,3,2003-03-20T05:00:00Z,2003-06-19T03:59:59Z,2025-05-13T15:35:49Z,03–6646,0,0,090000648049c843
FDA-2000-N-0108-0001,FDA,FDA-2000-N-0108,Notice of Proposed Rulemaking re Safety Reporting Requirements for Human Drug and Biological Products See FDA-2000-N-0108-0006,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2003-03-18T05:00:00Z,2003,3,2003-03-18T05:00:00Z,2003-07-15T03:59:59Z,2016-12-24T19:42:06Z,,0,0,09000064804c265e
FDA-2000-N-0108-0006,FDA,FDA-2000-N-0108,Notice of Proposed Rulemaking re Safety Reporting Requirements for Human Drug and Biological Products,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2003-03-18T05:00:00Z,2003,3,2003-03-18T05:00:00Z,2003-07-15T03:59:59Z,2016-02-24T19:29:20Z,,0,0,09000064804c2702
FDA-2000-N-0108-0003,FDA,FDA-2000-N-0108,See FDA-2000-N-0108-0006,Proposed Rule,,2003-03-18T00:00:00Z,2003,3,,,2016-03-02T20:23:54Z,,0,1,09000064804c26fb
FDA-1996-N-0028-0009,FDA,FDA-1996-N-0028,"Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding for Dietary Supplements, 3/13/2003 - Notice of Proposed Rule (Pgs 172-332)",Proposed Rule,NPR-Notice of Proposed Rule-Making,2003-03-17T05:00:00Z,2003,3,2003-03-17T05:00:00Z,2003-06-12T03:59:59Z,2009-09-11T20:43:48Z,,0,0,09000064804fb8bf
FDA-1996-N-0028-0012,FDA,FDA-1996-N-0028,"Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding for Dietary Supplements, 3/13/2003 - Notice of Proposed Rule (Pgs 480-546)",Proposed Rule,NPR-Notice of Proposed Rule-Making,2003-03-17T05:00:00Z,2003,3,2003-03-17T05:00:00Z,2003-06-12T03:59:59Z,2009-09-11T20:40:28Z,,0,0,09000064804fb8c3
FDA-1996-N-0028-0011,FDA,FDA-1996-N-0028,"Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding for Dietary Supplements, 3/13/2003 - Notice of Proposed Rule (Pgs 1-171)",Proposed Rule,NPR-Notice of Proposed Rule-Making,2003-03-17T05:00:00Z,2003,3,2003-03-17T05:00:00Z,2003-06-12T03:59:59Z,2009-09-11T20:38:55Z,,0,0,09000064804fb8c1
FDA-1996-N-0028-0010,FDA,FDA-1996-N-0028,"Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding for Dietary Supplements, 3/13/2003 - Notice of Proposed Rule (Pgs 333-479)",Proposed Rule,NPR-Notice of Proposed Rule-Making,2003-03-17T05:00:00Z,2003,3,2003-03-17T05:00:00Z,2003-06-12T03:59:59Z,2009-09-11T20:42:48Z,,0,0,09000064804fb8c0